ATP Assays Market Size, Share, Trends, Industry Analysis Report By Type, By Application, By End Use, By Region

Description

List of Tables

The ATP assays market size is expected to reach USD 7.23 billion by 2034, according to a new study by Polaris Market Research. The report "ATP Assays Market Share, Size, Trends, Industry Analysis Report By Type [Luminometric ATP Assays, Enzymatic ATP Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP Assays, Cell-based ATP Assays, Others], By Application, By End Use, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

ATP (adenosine triphosphate) assays are biochemical tests used to measure the concentration of ATP in biological samples, providing insights into cellular metabolism, viability, and energy status. ATP, the primary energy carrier for cellular processes, is essential in drug discovery informatics, microbiology, environmental monitoring, and cancer research.

The principle behind ATP assays relies on the enzymatic conversion of ATP to light, typically using luciferase, an enzyme derived from fireflies. In the presence of ATP, luciferase catalyzes the oxidation of luciferin, emitting bioluminescence that is proportional to the ATP concentration. This reaction is highly sensitive, allowing detection of even femtomole levels of ATP.

ATP assays are widely used in cell viability and cytotoxicity studies. In drug development, they help screen compounds for toxic effects by measuring ATP depletion in treated cells, indicating cell death or metabolic inhibition. Similarly, in cancer research, ATP assays evaluate the efficacy of chemotherapeutic agents by monitoring ATP levels in tumor cells. Microbial viability testing also employs ATP assays to detect contamination in water, food, and pharmaceuticals, as living microorganisms contain measurable ATP.

ATP Assays Market Report Highlights

In terms of type, the luminometric ATP assays segment held 33.12% of revenue share in 2024 due to its widespread adoption across pharmaceutical, biotechnology, and food and beverage industries.

Based on application, the drug discovery segment accounted for 34.17% of the revenue share in 2024, driven by the increasing demand for rapid and reliable methods to evaluate cell viability, cytotoxicity, and compound efficacy.

In terms of end use, the pharmaceutical and biotechnology companies segment dominated the revenue share in 2024 by holding 40.23% of the share. This is attributed to the increasing reliance on cellular energy measurements during drug screening, toxicity testing, and evaluations of therapeutic efficacy.

North America accounted for a 38.15% share of the global ATP assays market revenue in 2024. This dominance is attributed to the region's strong biotechnology and pharmaceutical industries, which rely on ATP detection for drug development, toxicity testing, and cell viability studies.

The market in Europe is projected to hold a substantial market share in 2034 due to strict regulatory frameworks that mandate ATP-based hygiene monitoring.

The industry in Asia Pacific is projected to grow at the fastest pace in the coming years, owing to expanding pharmaceutical and biotechnology industries, particularly in China, India, and Japan.

A few global key players in the ATP assays market include Abcam plc; Becton, Dickinson and Company (BD); Biomerieux SA; Biotium; Danaher Corporation; Lonza Group Ltd.; Merck KGaA; PerkinElmer Inc.; Promega Corporation; Quest Diagnostics Incorporated; Reaction Biology; and Thermo Fisher Scientific.

Polaris Market Research has segmented the ATP assays market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Luminometric ATP Assays

Enzymatic ATP Assays

Bioluminescence Resonance Energy Transfer (BRET) ATP Assays

Cell-based ATP Assays

Others

By Application Mode Outlook (Revenue, USD Billion, 2020-2034)

Drug Discovery and Development

Clinical Diagnostics

Environmental Testing

Food Safety and Quality Testing

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Hospital and Diagnostics Laboratories

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM6130

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global ATP Assays Market Insights

4.1. ATP Assays Market - Market Snapshot
4.2. ATP Assays Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Expanding application in Pharmaceutical and Biotechnology Research
  - 4.2.1.2. Rising Burden of Chronic Diseases
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of specificity for microbial vs. non-microbial ATP
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. ATP Assays Market End Use Trends
4.6. Value Chain Analysis

5. Global ATP Assays Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global ATP Assays Market, by Type, 2020-2034 (USD Billion)
5.3. Luminometric ATP Assays
- 5.3.1. Global ATP Assays Market, by Luminometric ATP Assays, by Region, 2020-2034 (USD Billion)
5.4. Enzymatic ATP Assays
- 5.4.1. Global ATP Assays Market, by Enzymatic ATP Assays, by Region, 2020-2034 (USD Billion)
5.5. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
- 5.5.1. Global ATP Assays Market, by Bioluminescence Resonance Energy Transfer (BRET) ATP Assays, by Region, 2020-2034 (USD Billion)
5.6. Cell-based ATP Assays
- 5.6.1. Global ATP Assays Market, by Cell-based ATP Assays, by Region, 2020-2034 (USD Billion)
5.7. Others
- 5.7.1. Global ATP Assays Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global ATP Assays Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global ATP Assays Market, by Application, 2020-2034 (USD Billion)
6.3. Drug Discovery and Development
- 6.3.1. Global ATP Assays Market, by Drug Discovery and Development, by Region, 2020-2034 (USD Billion)
6.4. Clinical Diagnostics
- 6.4.1. Global ATP Assays Market, by Clinical Diagnostics, by Region, 2020-2034 (USD Billion)
6.5. Environmental Testing
- 6.5.1. Global ATP Assays Market, by Environmental Testing, by Region, 2020-2034 (USD Billion)
6.6. Food Safety and Quality Testing
- 6.6.1. Global ATP Assays Market, by Food Safety and Quality Testing, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global ATP Assays Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global ATP Assays Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global ATP Assays Market, by End Use, 2020-2034 (USD Billion)
7.3. Pharmaceutical and Biotechnology Companies
- 7.3.1. Global ATP Assays Market, by Pharmaceutical and Biotechnology Companies, by Region, 2020-2034 (USD Billion)
7.4. Academic and Research Institutes
- 7.4.1. Global ATP Assays Market, by Academic and Research Institutes, by Region, 2020-2034 (USD Billion)
7.5. Hospital and Diagnostics Laboratories
- 7.5.1. Global ATP Assays Market, by Hospital and Diagnostics Laboratories, by Region, 2020-2034 (USD Billion)

8. Global ATP Assays Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. ATP Assays Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. ATP Assays Market - North America
- 8.3.1. North America: ATP Assays Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: ATP Assays Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.3.4. ATP Assays Market - U.S.
  - 8.3.4.1. U.S.: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.3.5. ATP Assays Market - Canada
  - 8.3.5.1. Canada: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
8.4. ATP Assays Market - Europe
- 8.4.1. Europe: ATP Assays Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: ATP Assays Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.4. ATP Assays Market - UK
  - 8.4.4.1. UK: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.5. ATP Assays Market - France
  - 8.4.5.1. France: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.5.3. France: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.6. ATP Assays Market - Germany
  - 8.4.6.1. Germany: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.7. ATP Assays Market - Italy
  - 8.4.7.1. Italy: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.8. ATP Assays Market - Spain
  - 8.4.8.1. Spain: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.9. ATP Assays Market - Netherlands
  - 8.4.9.1. Netherlands: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.10. ATP Assays Market - Russia
  - 8.4.10.1. Russia: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.4.11. ATP Assays Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
8.5. ATP Assays Market - Asia Pacific
- 8.5.1. Asia Pacific: ATP Assays Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: ATP Assays Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.4. ATP Assays Market - China
  - 8.5.4.1. China: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.4.3. China: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.5. ATP Assays Market - India
  - 8.5.5.1. India: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.5.3. India: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.6. ATP Assays Market - Malaysia
  - 8.5.6.1. Malaysia: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.7. ATP Assays Market - Japan
  - 8.5.7.1. Japan: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.8. ATP Assays Market - Indonesia
  - 8.5.8.1. Indonesia: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.9. ATP Assays Market - South Korea
  - 8.5.9.1. South Korea: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.10. ATP Assays Market - Australia
  - 8.5.10.1. Australia: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.5.11. ATP Assays Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
8.6. ATP Assays Market - Middle East & Africa
- 8.6.1. Middle East & Africa: ATP Assays Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: ATP Assays Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.6.4. ATP Assays Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.6.5. ATP Assays Market - UAE
  - 8.6.5.1. UAE: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.6.6. ATP Assays Market - Israel
  - 8.6.6.1. Israel: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.6.7. ATP Assays Market - South Africa
  - 8.6.7.1. South Africa: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.6.8. ATP Assays Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
8.7. ATP Assays Market - Latin America
- 8.7.1. Latin America: ATP Assays Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: ATP Assays Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.7.4. ATP Assays Market - Mexico
  - 8.7.4.1. Mexico: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.7.5. ATP Assays Market - Brazil
  - 8.7.5.1. Brazil: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.7.6. ATP Assays Market - Argentina
  - 8.7.6.1. Argentina: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: ATP Assays Market, by End Use, 2020-2034 (USD Billion)
- 8.7.7. ATP Assays Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: ATP Assays Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: ATP Assays Market, by Application, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: ATP Assays Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abcam plc
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Becton, Dickinson and Company (BD)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Biomerieux SA
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Biotium
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Danaher Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Lonza Group Ltd.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Merck KGaA
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. PerkinElmer Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Promega Corporation
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Quest Diagnostics Incorporated
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Reaction Biology
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Thermo Fisher Scientific
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development